| Name | Title | Contact Details |
|---|---|---|
Michael Bastian |
Chief Intellectual Property Counsel | Profile |
Agnieszka Gallagher |
Chief Legal Officer | Profile |
Nicholas Khadder |
SVP, General Counsel and Corporate Secretary | Profile |
VelosBio Inc. is a clinical-stage biopharmaceutical company committed to developing novel, first-in-class, ROR1-directed therapeutics to transform the lives of patients with cancer. Its lead candidate, VLS-101, is a ROR1-directed ADC being developed for patients with hematologic and solid tumor malignancies. The company is developing a broad pipeline of therapeutics targeting ROR1 in oncologic indications with high unmet medical need.
Styker Biotech is a West Lebanon, NH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Statistical Center for HIV/AIDS Research & Prevention is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Avellino is a global leader in precision medicine, focused on innovative genetic diagnostics, gene therapies, and genetic data for modern eyecare practices.
Aktis Oncology is a biotechnology company pioneering the discovery and development of a new class of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers.